XERESE Drug Patent Profile
✉ Email this page to a colleague
When do Xerese patents expire, and what generic alternatives are available?
Xerese is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in XERESE is acyclovir; hydrocortisone. There are fifty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acyclovir; hydrocortisone profile page.
Summary for XERESE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Clinical Trials: | 1 |
Patent Applications: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for XERESE |
What excipients (inactive ingredients) are in XERESE? | XERESE excipients list |
DailyMed Link: | XERESE at DailyMed |


Recent Clinical Trials for XERESE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Meda Pharmaceuticals | Phase 3 |
TKL Research, Inc. | Phase 3 |
Pharmacology for XERESE
Anatomical Therapeutic Chemical (ATC) Classes for XERESE
US Patents and Regulatory Information for XERESE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | XERESE | acyclovir; hydrocortisone | CREAM;TOPICAL | 022436-001 | Jul 31, 2009 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for XERESE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | XERESE | acyclovir; hydrocortisone | CREAM;TOPICAL | 022436-001 | Jul 31, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Bausch | XERESE | acyclovir; hydrocortisone | CREAM;TOPICAL | 022436-001 | Jul 31, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Bausch | XERESE | acyclovir; hydrocortisone | CREAM;TOPICAL | 022436-001 | Jul 31, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for XERESE
See the table below for patents covering XERESE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Yugoslavia | 49477 | ⤷ Try a Trial | |
South Korea | 100431042 | ⤷ Try a Trial | |
Spain | 2214528 | ⤷ Try a Trial | |
Croatia | P960034 | NOVEL PHARMACEUTICAL COMBINATION | ⤷ Try a Trial |
Austria | 238796 | ⤷ Try a Trial | |
New Zealand | 301407 | TOPICAL COMPOSITION COMPRISING AN ANTIINFLAMMATORY GLUCOCORTICOID AND AN ANTIVIRAL SUCH AS ACYCLOVIR | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for XERESE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0809498 | 10C0038 | France | ⤷ Try a Trial | PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026 |
0809498 | CA 2010 00009 | Denmark | ⤷ Try a Trial | |
0809498 | SPC/GB10/012 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |